Duke University

Treatment of atrial fibrillation with asundexian, a novel factor XIa inhibitor, was associated with increased stroke and systemic embolism risk despite lower bleeding risk compared with apixaban, a speaker reported.

SGLT2 inhibitors were associated with similar renal and CV outcomes vs. GLP-1 receptor agonists for patients with diabetes, regardless of chronic kidney disease status, researchers reported.

Older patients who had a primary care visit within 90 days after cancer surgery exhibited significantly reduced mortality risk, according to retrospective study results.

American Society for Radiation Oncology selected 48 members to receive ASTRO fellow designation.

Results presented at the Musculoskeletal Infection Society Annual Meeting showed the 2018 International Consensus Meeting criteria may effectively identify periprosthetic joint infection in revision shoulder arthroplasty.

Because the science underpinning medicine evolves so quickly, it is not uncommon for some doctors to manage patients based on old evidence that is no longer a best practice; this is called clinical inertia.

PHILADELPHIA — In the cardiovascular outcomes analysis of the GRADE trial, liraglutide was linked to lower risk for certain CV outcomes compared with other glucose-lowering therapies, researchers reported.

PHILADELPHIA — In this Healio video exclusive, Neha J. Pagidipati, MD, MPH, highlights growing evidence on the relationship between weight change and risk for cardiovascular disease.

A common cardiac amyloidosis-causing gene believed to be present in around 3% of the Black U.S. population is associated with increased risk for HF hospitalization and death, which increases with age, a speaker reported.

Individuals who ranked highest on a scale measuring social vulnerability by location had a poorer prognosis following colorectal resection, according to a presentation at Southern Surgical Association Annual Meeting.